Cargando…

Integrated single-cell and bulk RNA sequencing analysis identifies a neoadjuvant chemotherapy-related gene signature for predicting survival and therapy in breast cancer

Neoadjuvant chemotherapy (NAC) is a well-established treatment modality for locally advanced breast cancer (BC). However, it can also result in severe toxicities while controlling tumors. Therefore, reliable predictive biomarkers are urgently needed to objectively and accurately predict NAC response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaojun, Feng, Ran, Guo, Junbin, Pan, Lihui, Yao, Yarong, Gao, Jinnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666338/ https://www.ncbi.nlm.nih.gov/pubmed/37996875 http://dx.doi.org/10.1186/s12920-023-01727-0

Ejemplares similares

Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer
por: Zhou, Zhiyang, et al.
Publicado: (2023)

Integrated single-cell and bulk RNA sequencing analysis identified pyroptosis-related signature for diagnosis and prognosis in osteoarthritis
por: Chen, Yanzhong, et al.
Publicado: (2023)

Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature
por: Wu, Yunhao, et al.
Publicado: (2023)

Integrated single-cell and bulk RNA sequencing analysis identifies a prognostic signature related to ferroptosis dependence in colorectal cancer
por: Xu, Xiaochen, et al.
Publicado: (2023)

Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data
por: Sun, Duanchen, et al.
Publicado: (2022)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta‐analysis
por: Fan, Mengying, et al.
Publicado: (2015)

Integration of single-cell and bulk RNA sequencing to establish a prognostic signature based on tumor-associated macrophages in colorectal cancer
por: Li, Hua, et al.
Publicado: (2023)

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma
por: Wu, Mengxi, et al.
Publicado: (2023)

Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer
por: Zheng, Hang, et al.
Publicado: (2021)

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
por: Stoll, Gautier, et al.
Publicado: (2014)

Integration of Bulk RNA Sequencing and Single-Cell RNA Sequencing to Reveal Uveal Melanoma Tumor Heterogeneity and Cells Related to Survival
por: Gao, Guohong, et al.
Publicado: (2022)

Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets
por: Zhang, Yongjian, et al.
Publicado: (2022)

Integrated proteome sequencing, bulk RNA sequencing and single-cell RNA sequencing to identify potential biomarkers in different grades of intervertebral disc degeneration
por: Yang, Xiao, et al.
Publicado: (2023)

Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma
por: Shi, Xuezhong, et al.
Publicado: (2022)

Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM
por: Liu, Yuyao, et al.
Publicado: (2023)

Editorial: Multimodal and Integrative Analysis of Single-Cell or Bulk Sequencing Data
por: Chen, Geng
Publicado: (2021)

Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques
por: He, Dabao, et al.
Publicado: (2023)

CaSpER identifies and visualizes CNV events by integrative analysis of single-cell or bulk RNA-sequencing data
por: Serin Harmanci, Akdes, et al.
Publicado: (2020)

Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
por: Zhang, Zhen, et al.
Publicado: (2022)

A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival
por: Barrón-Gallardo, Carlos A., et al.
Publicado: (2022)

Peripheral immune cell death in sepsis based on bulk RNA and single-cell RNA sequencing
por: Liu, Shanshou, et al.
Publicado: (2023)

Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2021)

Neoadjuvant chemotherapy response, disease-free survival, and overall survival of breast cancer in a single institution
por: Prihantono, et al.
Publicado: (2023)

Intraoperative imaging identifies thymoma margins following neoadjuvant chemotherapy
por: Keating, Jane J., et al.
Publicado: (2015)

Editorial: Integrative analysis of single-cell and/or bulk multi-omics sequencing data
por: Chen, Geng, et al.
Publicado: (2023)

Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021)

T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
por: Chi, Hao, et al.
Publicado: (2023)

Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer
por: Chen, Fangyue, et al.
Publicado: (2023)

Bulk RKKY signatures of topological phase transition in silicene
por: Duan, Hou-Jian, et al.
Publicado: (2018)

Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head and neck squamous carcinoma by integrated analysis of single-cell and bulk RNA-sequencing
por: Zhou, Chongchang, et al.
Publicado: (2023)

Bulk RNA Sequencing With Integrated Single-Cell RNA Sequencing Identifies BCL2A1 as a Potential Diagnostic and Prognostic Biomarker for Sepsis
por: Li, Jun, et al.
Publicado: (2022)

Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Signature-scoring methods developed for bulk samples are not adequate for cancer single-cell RNA sequencing data
por: Noureen, Nighat, et al.
Publicado: (2022)

Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer
por: Wang, Ruisong, et al.
Publicado: (2022)

ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
por: Alva-Ruiz, Roberto, et al.
Publicado: (2021)

Integration of single-cell sequencing and bulk expression data reveals chemokine signaling pathway in proliferating cells is associated with the survival outcome of osteosarcoma
por: Yu, Lin, et al.
Publicado: (2023)

8-Gene signature related to CD8(+) T cell infiltration by integrating single-cell and bulk RNA-sequencing in head and neck squamous cell carcinoma
por: Zhang, Shoujing, et al.
Publicado: (2022)

Integrated single-cell and bulk RNA sequencing analyses reveal a prognostic signature of cancer-associated fibroblasts in head and neck squamous cell carcinoma
por: Yang, Yichen, et al.
Publicado: (2022)

Identification and validation of a signature based on macrophage cell marker genes to predict recurrent miscarriage by integrated analysis of single-cell and bulk RNA-sequencing
por: Wei, Peiru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0pre3lmpdbrqua3l6s6mevmiai